LA
EVH icon

Lee Ainslie’s Evolent Health EVH Stock Holding History

Lee Ainslie’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,572,763
Closed -$5.87M – 224
2026
Q1 		$5.87M Buy
2,572,763
+32,833
+1% +$104K 0.07% 55
2025
Q4 		$10.2M Buy
2,539,930
+144,646
+6% +$804K 0.11% 54
2025
Q3 		$20.3M Buy
2,395,284
+1,002,760
+72% +$9.73M 0.27% 53
2025
Q2 		$15.7M Buy
+1,392,524
New +$12.8M 0.24% 50
2023
Q2 		– Sell
-11,451
Closed -$372K – 454
2023
Q1 		$372K Buy
+11,451
New +$362K 0.01% 368
2021
Q4 		– Sell
-21,130
Closed -$655K – 428
2021
Q3 		$655K Buy
+21,130
New +$507K 0.01% 399

Other funds holding EVH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Cadian Capital Management New York $1.32B AUM 4.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Lee Ainslie's EVH Position: Q2 2026 in Review

Lee Ainslie sold out of Evolent Health (EVH) in Q2 2026, closing a stake of 2,572,763 shares — an estimated $5.87M sold.

Lee Ainslie first reported a position in EVH in Q3 2021 and held it in 6 quarters. The position peaked at $20.3M in Q3 2025. 198 funds tracked by Wall St. Rank hold EVH as of Q2 2026.

  • Lee Ainslie reported no remaining Evolent Health position as of Q2 2026 after selling out during the quarter.
  • Lee Ainslie sold 2,572,763 Evolent Health shares in Q2 2026, an estimated $5.87M.
  • Lee Ainslie first reported a position in Evolent Health in Q3 2021 and held it in 6 quarters.
  • Lee Ainslie's Evolent Health position peaked at $20.3M in Q3 2025.
  • 198 funds tracked by Wall St. Rank held Evolent Health as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.